VERUCERFONT

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C22H26N6O2
Molecular Weight	406.4808
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of VERUCERFONT

Structure Search

SMILES

CC[C@H](NC1=CC(C)=NC2=C(C(C)=NN12)C3=C(C)C=C(OC)C=C3)C4=NC(C)=NO4

InChI

InChIKey=VKHVAUKFLBBZFJ-SFHVURJKSA-N

InChI=1S/C22H26N6O2/c1-7-18(22-24-15(5)27-30-22)25-19-11-13(3)23-21-20(14(4)26-28(19)21)17-9-8-16(29-6)10-12(17)2/h8-11,18,25H,7H2,1-6H3/t18-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C22H26N6O2
Molecular Weight	406.4808
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 17:35:30 UTC 2023` Edited by `admin` on `Sat Dec 16 17:35:30 UTC 2023`
Record UNII	X60608B091
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

VERUCERFONT

Official Name

English

GSK-561679

Code

English

3-(4-Methoxy-2-methylphenyl)-2,5-dimethyl-N-[(1S)-1-(3-methyl-1,2,4-oxadiazol-5-yl)propyl]pyrazolo[1,5-a]pyrimidin-7-amine

Systematic Name

English

VERUCERFONT [USAN]

Common Name

English

GSK-561679A

Code

English

Verucerfont [WHO-DD]

Common Name

English

PYRAZOLO(1,5-A)PYRIMIDIN-7-AMINE, 3-(4-METHOXY-2-METHYLPHENYL)-2,5-DIMETHYL-N-((1S)-1-(3-METHYL-1,2,4-OXADIAZOL-5-YL)PROPYL)-

Systematic Name

English

verucerfont [INN]

Common Name

English

GSK561679A

Code

English

GSK-561,679

Code

English

NBI-77860

Code

English

Classification Tree Code System Code

FDA ORPHAN DRUG

399713

Created by admin on Sat Dec 16 17:35:30 UTC 2023 , Edited by admin on Sat Dec 16 17:35:30 UTC 2023

NCI_THESAURUS

C2355

Created by admin on Sat Dec 16 17:35:30 UTC 2023 , Edited by admin on Sat Dec 16 17:35:30 UTC 2023

EU-Orphan Drug

EU/3/15/1537

Created by admin on Sat Dec 16 17:35:30 UTC 2023 , Edited by admin on Sat Dec 16 17:35:30 UTC 2023

Code System Code Type Description

DRUG BANK

DB12512

Created by admin on Sat Dec 16 17:35:30 UTC 2023 , Edited by admin on Sat Dec 16 17:35:30 UTC 2023

PRIMARY

EPA CompTox

DTXSID501032013

Created by admin on Sat Dec 16 17:35:30 UTC 2023 , Edited by admin on Sat Dec 16 17:35:30 UTC 2023

PRIMARY

FDA UNII

X60608B091

Created by admin on Sat Dec 16 17:35:30 UTC 2023 , Edited by admin on Sat Dec 16 17:35:30 UTC 2023

PRIMARY

WIKIPEDIA

VERUCERFONT

Created by admin on Sat Dec 16 17:35:30 UTC 2023 , Edited by admin on Sat Dec 16 17:35:30 UTC 2023

PRIMARY

SMS_ID

100000177256

Created by admin on Sat Dec 16 17:35:30 UTC 2023 , Edited by admin on Sat Dec 16 17:35:30 UTC 2023

PRIMARY

PUBCHEM

11596613

Created by admin on Sat Dec 16 17:35:30 UTC 2023 , Edited by admin on Sat Dec 16 17:35:30 UTC 2023

PRIMARY

CAS

885220-61-1

Created by admin on Sat Dec 16 17:35:30 UTC 2023 , Edited by admin on Sat Dec 16 17:35:30 UTC 2023

PRIMARY

NCI_THESAURUS

C152869

Created by admin on Sat Dec 16 17:35:30 UTC 2023 , Edited by admin on Sat Dec 16 17:35:30 UTC 2023

PRIMARY

ChEMBL

CHEMBL1287935

Created by admin on Sat Dec 16 17:35:30 UTC 2023 , Edited by admin on Sat Dec 16 17:35:30 UTC 2023

PRIMARY

INN

9197

Created by admin on Sat Dec 16 17:35:30 UTC 2023 , Edited by admin on Sat Dec 16 17:35:30 UTC 2023

PRIMARY

USAN

UU-141

Created by admin on Sat Dec 16 17:35:30 UTC 2023 , Edited by admin on Sat Dec 16 17:35:30 UTC 2023

PRIMARY

Related Record Type Details


					5CLY6W2H1M

CORTICOTROPIN-RELEASING FACTOR RECEPTOR 1

TARGET -> INHIBITOR

Qualification:

Ki

Amount:

Related Record Type Details


					X60608B091

ACTIVE MOIETY